The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression
Authors:
Open Access
- 1 March 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (11) , e6333
Abstract
The purpose of this meta-analysis was to evaluate the diagnostic accuracy of perfusion magnetic resonance imaging (MRI) as a method for differentiating glioma recurrence from pseudoprogression. The PubMed, Embase, Cochrane Library, and Chinese Biomedical databases were searched comprehensively for relevant studies up to August 3, 2016 according to specific inclusion and exclusion criteria. The quality of the included studies was assessed according to the quality assessment of diagnostic accuracy studies (QUADAS-2). After performing heterogeneity and threshold effect tests, pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were calculated. Publication bias was evaluated visually by a funnel plot and quantitatively using Deek funnel plot asymmetry test. The area under the summary receiver operating characteristic curve was calculated to demonstrate the diagnostic performance of perfusion MRI. Eleven studies covering 416 patients and 418 lesions were included in this meta-analysis. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.88 (95% confidence interval [CI] 0.84–0.92), 0.77 (95% CI 0.69–0.84), 3.93 (95% CI 2.83–5.46), 0.16 (95% CI 0.11–0.22), and 27.17 (95% CI 14.96–49.35), respectively. The area under the summary receiver operating characteristic curve was 0.8899. There was no notable publication bias. Sensitivity analysis showed that the meta-analysis results were stable and credible. While perfusion MRI is not the ideal diagnostic method for differentiating glioma recurrence from pseudoprogression, it could improve diagnostic accuracy. Therefore, further research on combining perfusion MRI with other imaging modalities is warranted.Keywords
This publication has 38 references indexed in Scilit:
- Comparison of diffusion tensor, dynamic susceptibility contrast MRI and 99mTc-Tetrofosmin brain SPECT for the detection of recurrent high-grade gliomaMagnetic Resonance Imaging, 2014
- Clinical application of perfusion computed tomography in neurosurgeryJournal of Neurosurgery, 2014
- Radiation Necrosis in the Brain: Imaging Features and Differentiation from Tumor RecurrenceRadioGraphics, 2012
- Comparison of 18F-Fluorodeoxyglucose and 18F-Fluorothymidine PET in Differentiating Radiation Necrosis From Recurrent GliomaClinical Nuclear Medicine, 2012
- Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial resultsJournal of Neuro-Oncology, 2011
- Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysisBMC Cancer, 2010
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapyBritish Journal of Cancer, 2002
- Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical TrialsJournal of Clinical Oncology, 1999
- Response criteria for phase II studies of supratentorial malignant glioma.Journal of Clinical Oncology, 1990